CapitalatWork SA’s Zimmer Biomet ZBH Stock Holding History

CapitalatWork SA’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.6M	Sell	297,000 -30,130	-9%	-$2.64M	0.64%	43
2026 Q1	$29.6M	Sell	327,130 -5,000	-2%	-$459K	0.88%	38
2025 Q4	$29.9M	Sell	332,130 -3,057	-0.9%	-$290K	0.91%	36
2025 Q3	$33M	Buy	335,187 +4,100	+1%	+$406K	0.96%	36
2025 Q2	$30.2M	Sell	331,087 -7,000	-2%	-$677K	0.92%	36
2025 Q1	$38.3M	Buy	338,087 +2,200	+0.7%	+$235K	1.24%	31
2024 Q4	$35.5M	Buy	335,887 +3,857	+1%	+$414K	1.15%	30
2024 Q3	$35.8M	Buy	332,030 +21,500	+7%	+$2.35M	1.22%	30
2024 Q2	$33.7M	Buy	310,530 +22,500	+8%	+$2.65M	1.13%	29
2024 Q1	$38M	Buy	288,030 +34,690	+14%	+$4.33M	1.27%	26
2023 Q4	$30.8M	Buy	+253,340	New	+$28.3M	1.12%	25

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CapitalatWork SA's ZBH Position: Q2 2026 in Review

CapitalatWork SA reduced its Zimmer Biomet (ZBH) stake by 9.2% in Q2 2026, selling an estimated $2.64M and leaving 297,000 shares worth $25.6M. The position accounts for 0.64% of the portfolio, ranked #43.

CapitalatWork SA first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $38.3M in Q1 2025. 902 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

CapitalatWork SA held 297,000 shares of Zimmer Biomet worth $25.6M as of Q2 2026.
CapitalatWork SA sold 30,130 Zimmer Biomet shares in Q2 2026, an estimated $2.64M.
Zimmer Biomet made up 0.64% of CapitalatWork SA's portfolio in Q2 2026, its #43 holding.
CapitalatWork SA first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
CapitalatWork SA's Zimmer Biomet position peaked at $38.3M in Q1 2025.
902 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on CapitalatWork SA's 13F filing for Q2 2026, filed 29 Jul 2026.